Pathophysiology and Management of Acute Coronary Syndromes

Published Online: Monday, March 25, 2013
Follow Pharmacy_Times:
In this podcast from the BMJ Group, Mark de Belder, MD, a consultant cardiologist, speaks to James McLenachan, MRCP, a fellow consultant cardiologist, and Keith Channon, MD, professor of cardiovascular medicine at the University of Oxford, about the pathophysiology and management of acute coronary syndromes. To listen to the podcast online, click here. To download it, click here.
Related Articles
The FDA has granted approval for the use of hemophilia B treatment Rixubis in pediatric patients.
New late-stage trial data show ivabradine reduces cardiovascular death or hospitalization for worsening chronic heart failure in patients with low systolic blood pressure.
The risk for developing prediabetes was doubled among hypertensive patients who drank more than 3 cups of coffee per day.
Involving pharmacists in the intensive care unit reduces adverse events and costs for patients who receive continuous veno-venous hemofiltration.
Latest Issues
$auto_registration$